Tick vaccines derived from Bm86, a midgut membrane-bound protein of the cattle tick, Boophilus microplus, are currently the only commercially available ectoparasite vaccines. Despite its introduction to the market in 1994, and the recognized need for alternatives to chemical pesticides, progress in developing effective antitick vaccines (and ectoparasite vaccines in general) is slow. The primary rate-limiting step is the identification of suitable antigenic targets for vaccine development. Tw...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases.
If you are the owner of this record, you can report an update to it here: Report update to this record